Your browser doesn't support javascript.
loading
CEP20 promotes invasion and metastasis of non-small cell lung cancer cells by depolymerizing microtubules.
Feng, Sijie; Yuan, Shuai; Hou, Baohua; Liu, Zhiqiang; Xu, Yanjun; Hao, Shuangying; Lu, Yunkun.
Affiliation
  • Feng S; School of Medicine, Henan Polytechnic University, Jiaozuo, China.
  • Yuan S; Jiaozuo Key Laboratory of Gynecological Oncology Medicine, Jiaozuo, China.
  • Hou B; School of Medicine, Henan Polytechnic University, Jiaozuo, China.
  • Liu Z; School of Medicine, Henan Polytechnic University, Jiaozuo, China.
  • Xu Y; School of Medicine, Henan Polytechnic University, Jiaozuo, China.
  • Hao S; Department of Medical Thoracic Oncology, The Cancer Hospital of the University of Chinese Academy of Sciences (Zhejiang Cancer Hospital), Institute of Basic Medicine and Cancer (IBMC), Chinese Academy of Sciences, Hangzhou, China.
  • Lu Y; School of Medicine, Henan Polytechnic University, Jiaozuo, China. shuangying9088@hpu.edu.cn.
Sci Rep ; 13(1): 17484, 2023 10 14.
Article de En | MEDLINE | ID: mdl-37838783
ABSTRACT
Worldwide, Lung cancer is the leading cause of cancer-related death and poses a direct health threat, non-small cell lung cancer (NSCLC) is the most common type. In this study, we demonstrated that centrosomal protein 20 (CEP20) is upregulated in NSCLC tissues and associated with cancer invasion metastasis. Notably, CEP20 depletion inhibited NSCLC cell proliferation, migration, and microtubule polymerization. Mechanistically, we discovered that CEP20 is critical in the development of NSCLC by regulating microtubule dynamics and cell adhesion-related signaling pathways. Furthermore, the knockdown or overexpression of CEP20 affects microtubule polymerization in A549 cell lines. Our research provides a promising therapeutic target for the diagnosis and treatment of lung cancer, as well as a theoretical and experimental basis for clinical application.
Sujet(s)

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Carcinome pulmonaire non à petites cellules / MicroARN / Tumeurs du poumon Limites: Humans Langue: En Journal: Sci Rep Année: 2023 Type de document: Article Pays d'affiliation: Chine

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Carcinome pulmonaire non à petites cellules / MicroARN / Tumeurs du poumon Limites: Humans Langue: En Journal: Sci Rep Année: 2023 Type de document: Article Pays d'affiliation: Chine